These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5774055)

  • 21. The effect of bretylium tosylate on ventricular function.
    Saunders WH; Behar VS
    Am J Med Sci; 1973 Apr; 265(4):287-95. PubMed ID: 4540979
    [No Abstract]   [Full Text] [Related]  

  • 22. The actions of verapamil on experimental arrhythmias.
    Rodrigues-Pereira E; Viana AP
    Arzneimittelforschung; 1968 Feb; 18(2):175-9. PubMed ID: 5695375
    [No Abstract]   [Full Text] [Related]  

  • 23. The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
    Schuster DP; Lucchesi BR; Nobel NL; Mimnaugh MN; Counsell RE; Kniffen FJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):213-27. PubMed ID: 4405548
    [No Abstract]   [Full Text] [Related]  

  • 24. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative mechanisms of antiarrhythmic agents.
    Pamintuan JC; Dreifus LS; Watanabe Y
    Am J Cardiol; 1970 Nov; 26(5):512-9. PubMed ID: 5478839
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacotherapy of cardiac arrhythmias in acute myocardial infarction.
    van Dijk L
    Folia Med Neerl; 1971; 14(5):225-36. PubMed ID: 4400908
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro preparation of infarcted myocardium.
    Sasyniuk BI
    Environ Health Perspect; 1978 Oct; 26():233-42. PubMed ID: 720317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Negative inotropic and local anesthetic effect of a -adrenergic blockader].
    Siro-Brigiani G; De Blasi S; Mitolo-Chieppa D
    Boll Soc Ital Biol Sper; 1972 May; 48(9):224-6. PubMed ID: 4403604
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical correlates of the electrophysiologic action of digitalis on the heart.
    Dreifus LS; Watanabe Y
    Semin Drug Treat; 1972; 2(2):179-201. PubMed ID: 4343767
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantitative assessment of antidysrhythmic drugs.
    Vaughan Williams EM
    G Ital Cardiol; 1972; 2(1):157. PubMed ID: 5011997
    [No Abstract]   [Full Text] [Related]  

  • 31. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 32. The experimental basis for the choice of an anti-arrhythmic drug.
    Vaughan Williams EM
    Adv Cardiol; 1970; 4():275-89. PubMed ID: 4395423
    [No Abstract]   [Full Text] [Related]  

  • 33. The preparation and the local anaesthetic action of some compounds related to 1-(benzylidenamino)-3,3-dimethylguanidine.
    Florvall LG; Akerman SB
    Acta Pharm Suec; 1972 Dec; 9(6):513-20. PubMed ID: 4656560
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.
    Papp JG; Williams EM
    Br J Pharmacol; 1969 Oct; 37(2):391-9. PubMed ID: 4390670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differing local anaesthetic potency and toxicity of the enantiomers of N-n-butyl-3-piperidyl 2'-chloro-6'-methylcarbanilate: a new local anaesthetic.
    Akerman B
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):97-111. PubMed ID: 4542533
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bretylium tosylate. A new anti-arrhythmia drug. Review].
    Arriaga Gracia J; Scampardonis G; Alexandrides K; González Hermosillo JA
    Arch Inst Cardiol Mex; 1972; 42(4):629-34. PubMed ID: 5073709
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta adrenergic antagonists, including ICI 50172, and the control of cardiac arrhythmias.
    Nayler WG; Chan J; Lowe TE
    Med J Aust; 1968 Jun; 1(26):1128-30. PubMed ID: 5667022
    [No Abstract]   [Full Text] [Related]  

  • 39. The anti-arrhythmic action of bretylium in normal reserpine-pretreated and chronically denervated dog hearts.
    Cervoni P; Ellis CH; Maxwell RA
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):91-102. PubMed ID: 5551205
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacology of dl-5-methyl-8-(2-hydroxy-3-t-butylaminopropoxy) coumarin hydrochloride (CS-359), a new beta-adrenergic blocking agent.
    Oshima T; Kumakura S; Koike H; Nakayama K
    Jpn J Pharmacol; 1973 Aug; 23(4):497-513. PubMed ID: 4148384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.